The cost of antibiotic resistance: Analysis and consequences;Coût biologique de la résistance aux antibiotiques : Analyse et conséquences

Pathologie Biologie

Volumn 60, Issue 2, 2012, Pages

  Kempf, I ^a   Zeitouni, S ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Antimicrobial resistance; Biological cost; Compensation; Evolution; Persistence; Reversibility

Indexed keywords

ANTIBIOTIC AGENT;

ADAPTATION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM MUTANT; EVOLUTION; GENETIC SELECTION; GROWTH RATE; HOST; IN VITRO STUDY; IN VIVO STUDY; REPRODUCTIVE FITNESS;

ADAPTATION, BIOLOGICAL; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COST OF ILLNESS; DRUG RESISTANCE, MICROBIAL; EVOLUTION, MOLECULAR; GENETIC FITNESS; HOST-PATHOGEN INTERACTIONS; HUMANS; MUTATION;

EID: 84859426192     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.10.013     Document Type: Article

References (53)

1. Chaslus-Dancla E., Gerbaud G., Lagorce M., Lafont J.P., Courvalin P. Persistence of an antibiotic resistance plasmid in intestinal Escherichia coli of chickens in the absence of selective pressure. Antimicrob Agents Chemother 1987, 31:784-788.
2. Nilsson O., Greko C., Top J., Franklin A., Bengtsson B. Spread without known selective pressure of a vancomycin-resistant clone of Enterococcus faecium among broilers. J Antimicrob Chemother 2009, 63:868-872.
3. Bean D.C., Livermore D.M., Hall L.M.C. Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistence. Antimicrob Agents Chemother 2009, 53:1088-1093.
4. Macvanin M., Bjorkman J., Eriksson S., Rhen M., Andersson D.I., Hughes D. Fusidic acid-resistant mutants of Salmonella enterica serovar typhi murium with low fitness in vivo are defective in RpoS induction. Antimicrob Agent Chemother 2003, 47:3743-3749.
5. Martinez J.L., Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 2002, 15:647-679.
6. Bjorkman J., Andersson D.I. The cost of antibiotic resistance from a bacterial perspective. Drug Resist Updat 2000, 3:237-245.
7. Andersson D.I. Persistence of antibiotic resistant bacteria. Curr Opin Microbiol 2003, 6:452-456.
8. Nilsson A.I., Berg O.G., Aspevall O., Kahlmeter G., Andersson D.I. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother 2003, 47:2850-2858.
9. Sandegren L., Lindqvist A., Kahlmeter G., Andersson D.I. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother 2008, 62:495-503.
10. Giraud E., Cloeckaert A., Baucheron S., Mouline C., Chaslus-Dancla E. Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar typhi murium. J Med Microbiol 2003, 52:697-703.
11. Enne V.I., Delsol A.A., Roe J.M., Bennett P.M. Rifampicin resistance and its fitness cost in Enterococcus faecium. J Antimicrob Chemother 2004, 53:203-207.
12. Lenski R.E., Rose M.R., Simpson S.C., Tadler S.C. Long-term experimental evolution in Escherichia coli. I. Adaptation and divergence during 2000 generations. Am Nat 1991, 138:1315-1341.
13. Wichelhaus T.A., Boddinghaus B., Besier S., Schafer V., Brade V., Ludwig A. Biological cost of rifampin resistance from the perspective of Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46:3381-3385.
14. Binet R., Maurelli A.T. Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BC. Antimicrob Agents Chemother 2005, 49:4455-4464.
15. Pranting M., Negrea A., Rhen M., Andersson D.I. Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar typhi murium LT2. Antimicrob Agents Chemother 2008, 52:2734-2741.
16. Sander P., Springer B., Prammananan T., Sturmfels A., Kappler M., Pletschette M., et al. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Chemother 2002, 46:1204-1211.
17. Ender M., McCallum N., Adhikari R., Berger-Bachi B. Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus. Antimicrob Agents Chemother 2004, 48:2295-2297.
18. Noto M.J., Fox P.M., Archer G.L. Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2008, 52:1221-1229.
19. Foucault M.L., Courvalin P., Grillot-Courvalin C. Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009, 53:2354-2359.
20. Enne V.I., Bennett P.M., Livermore D.M., Hall L.M.C. Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure. J Antimicrob Chemother 2004, 53:958-963.
21. Enne V.I., Delsol A.A., Davis G.R., Hayward S.L., Roe J.M., Bennett P.M. Assessment of the fitness impacts on Escherichia of acquisition of antibiotic resistance genes encoded by different types of genetic element. J Antimicrob Chemother 2005, 56:544-551.
22. Sanchez P., Linares J.F., Ruiz-Diez B., Campanario E., Navas A., Baquero F., et al. Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J Antimicrob Chemother 2002, 50:657-664.
23. Han F., Pu S. Fitness cost of macrolide resistance in Campylobacter jejuni. Int J Antimicrob Agents 2009, 34:462-466.
24. Bjorkman J., Hughes D., Andersson D.I. Virulence of antibiotic-resistant Salmonella typhi murium. Proc Natl Acad Sci U S A 1998, 95:3949-3953.
25. Sun S., Negrea A., Rhen M., Andersson D.I. Genetic analysis of colistin resistance in Salmonella enterica serovar typhi murium. Antimicrob Agents Chemother 2009, 53:2298-2305.
26. Lindgren P.K., Marcusson L.L., Sandvang D., Frimodt-Moller N., Hughes D. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother 2005, 49:2343-2351.
27. Yu J., Wu J., Francis K.P., Purchio T.F., Kadurugamuwa J.L. Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model. J Antimicrob Chemother 2005, 55:528-534.
28. Paulander W., Pennhag A., Andersson D.I., Maisnier-Patin S. Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhi murium. Antimicrob Agents Chemother 2007, 51:766-769.
29. Luo N., Zhang Q., Naidan L., Sonia P., Orhan S. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc Natl Acad Sci USA 2005, 102:541-546.
30. Gustafsson I., Cars O., Andersson D.I. Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers. J Antimicrob Chemother 2003, 52:258-263.
31. Morosini M.I., Ayala J.A., Baquero F., Martinez J.L., Blazquez J. Biological cost of AmpC production for Salmonella enterica serotype typhi murium. Antimicrob Agents Chemother 2000, 44:3137-3143.
32. Wang Y.P., Li L., Shen J.Z., Yang F.J., Wu Y.N. Quinolone-resistance in Salmonella is associated with decreased mRNA expression of virulence genes invA and avrA, growth and intracellular invasion and survival. Vet Microbiol 2009, 133:328-334.
33. Maisnier-Patin S., Berg O.G., Liljas L., Andersson D.I. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhi murium. Mol Microbiol 2002, 46:355-366.
34. Kugelberg E., Lofmark S., Wretlind B., Andersson D.I. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa. J Antimicrob Chemother 2005, 55:22-30.
35. O'Neill A.J., Huovinen T., Fishwick C.W.G., Chopra I. Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother 2006, 50:298-309.
36. Bjorkman J., Nagaev I., Berg O.G., Hughes D., Andersson D.I. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 2000, 287:1479-1482.
37. Paulander W., Maisnier-Patin S., Andersson D.I. Multiple mechanisms to ameliorate the fitness burden of mupirocin resistance in Salmonella typhi murium. Mol Microbiol 2007, 64:1038-1048.
38. Bouma J.E., Lenski R.E. Evolution of a bacteria/plasmid association. Nature 1988, 335:351-352.
39. Lenski R.E., Souza V., Duong L.P., Phan Q.G., Nguyen T.N.M., Bertrand K.P. Epistatic effects of promoter and repressor functions of the Tn10 tetracycline-resistance operon on the fitness of Escherichia coli. Mol Ecol 1994, 3:127-135.
40. Hossain A., Reisbig M.D., Hanson N.D. Plasmid-encoded functions compensate for the biological cost of AmpC overexpression in a clinical isolate of Salmonella typhi murium. J Antimicrob Chemother 2004, 53:964-970.
41. Enne V.I., Delsol A.A., Roe J.M., Bennett P.M. Evidence of antibiotic resistance gene silencing in Escherichia coli. Antimicrob Agents Chemother 2006, 50:3003-3010.
42. Girgis H.S., Hottes A.K., Tavazoie S. Genetic architecture of intrinsic antibiotic susceptibility. PLoS ONE 2009, 4:1-13.
43. Schrag S.J., Perrot V., Levin B.R. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc R Soc Lond B Biol Sci 1997, 264:1287-1291.
44. Andersson D.I. The biological cost of mutational antibiotic resistance: any practical conclusions?. Curr Opin Microbiol 2006, 9:461-465.
45. McCallum N., Karauzum H., Getzmann R., Bischoff M., Majcherczyk P., Berger-Bachi B., et al. In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance. Antimicrob Agents Chemother 2006, 50:2352-2360.
46. Hurdle J.G., O'Neill A.J., Ingham E., Fishwick C., Chopra I. Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques. Antimicrob Agents Chemother 2004, 48:4366-4376.
47. Macvanin M., Hughes D. Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics. FEMS Microbiol Lett 2005, 247:215-220.
48. Hurdle J.G., O'Neill A.J., Chopra I. The isoleucyl-tRNA synthetase mutation V588F conferring mupirocin resistance in glycopeptide-intermediate Staphylococcus aureus is not associated with a significant fitness burden. J Antimicrob Chemother 2004, 53:102-104.
49. Andersson D.I., Levin B.R. The biological cost of antibiotic resistance. Curr Opin Microbiol 1999, 2:489-493.
50. Pfister P, Corti N, Hobbie S, Bruell C, Zarivach R, Yonath A, et al. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058Aâ†'G. Proc Natl Acad Sci U S A 2005;102:5180-5.
51. Bjorkholm B., Sjolund M., Falk P.G., Berg O.G., Engstrand L., Andersson D.I. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci U S A 2001, 98:14607-14612.
52. Levin B.R., Perrot V., Walker N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 2000, 154:985-997.
53. Johnsen P.J., Simonsen G.S., Olsvika, Midtvedt T., Sundsfjord A. Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice. Microb Drug Resist 2002, 8:161-170.